TXG Trading Analysis - 10/29/2026 10:24 AM — TRU-SENTIMENT

TXG (10x Genomics Inc. Class A Common Stock) at $83.66. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $2,760 vs put $0. RSI 57.5.

TRU-SENTIMENT · DeltaNeutral

TXG Trading Analysis - 10/29/2026 10:24 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

TXG (10x Genomics Inc. Class A Common Stock) at $83.66. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $2,760 vs put $0. RSI 57.5.

Symbol
TXG
Price
$83.66
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-10-29 10:24:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only):

Call Volume: $2,760.00 (100.00%) Put Volume: $0.00 (0.00%) Total: $2,760.00

Sentiment is Bullish with 3 call contracts, 0 puts, 2 call trades. Pure directional conviction is entirely bullish but on very low sample (2 of 244 options analyzed, 0.80% filter). Near-term expectations: tentative upside bias, no bearish hedge. Divergence: technical SMA stack is irregular and fundamentals negative, yet options show 100% call conviction — small-size optimism not confirmed by broader data.

Note: Options flow shows 100% call dollar volume in delta-40-60 bracket, the only sentiment source retrieved.

Key Statistics: TXG

$82.73 -1.45%
52-Week Range
$12.34 - $102.81
Market Cap
$10.78B
P/E (TTM)
N/A
PEG Ratio
N/A
Beta
1.72
Next Earnings
N/A
Avg Volume
$2.72M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

EPS (trailing 12 mo)$-0.59
Market cap$10.78B
Shares outstanding130.3M

Dividend

Dividend yield0.00%

Risk & range

Beta1.72
52-week low$12.34
52-week high$102.81
Historical volatility92.2%

Ownership & trading

Institutional ownership76.5%
Average daily volume4.0M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

Recent general-knowledge headlines and context for 10x Genomics (TXG) that may frame the data below:

  • 10x Genomics announced new single-cell RNA-seq instrument upgrades aimed at improving lab throughput, potentially supporting longer-term adoption.
  • Company reported a prior-quarter operating loss with negative EPS, consistent with its early-profitability biotech profile and high cash-burn risk.
  • Broader genomics-tools demand showed uneven academic spending, a recurring catalyst that can pressure TXG revenue visibility.
  • No confirmed near-term earnings date in provided data; fiscal year end listed as 2025-12-01, suggesting seasonal fundamental updates may be stale.
  • Headlines lean cautiously constructive on product cycle but do not offset the negative EPS and high-beta volatility seen in the embedded fundamentals and technicals.

Context: News of product upgrades contrasts with the negative trailing EPS (-0.59) and elevated historical volatility (92.21%) in the data, while the bullish delta-40-60 options flow suggests tactical optimism not yet backed by fundamental profitability.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for TXG:

  • Trailing EPS is -0.59; company is not profitable on a trailing basis (trailingPE null, forwardPE null).
  • Revenue growth, gross/operating/net margins, ROE, and profit margins are null in the data — not available for trend analysis.
  • P/E and PEG ratio are null; valuation cannot be compared via multiples, only via price-to-book (null) and market cap of $10,778,974,430.00.
  • Debt/equity, free cash flow, and target mean price are null; analyst consensus and recommendations are null.
  • Strengths: Institutional ownership is 76.51%, average volume 4,040,000, and 52-week range of $12.34 to $102.81 shows extreme recovery potential.
  • Concerns: Beta 1.72 and historical volatility 92.21% imply high systematic risk; negative EPS and missing profitability metrics diverge from the bullish technical and options flow.

Fundamentals show a pre-profit biotech with high institutional interest but no earnings support, diverging from the bullish technical and sentiment reads in the embedded data.

Current Market Position

Current price per indicators is $83.95 (2026-10-28 close $83.95). Recent daily action: 2026-10-28 opened $78.93, high $87.82, low $78.25, close $83.95 on volume 4,100,292 — a strong rebound from $78.31 on 2026-10-27. Minute bars show 2026-10-28 09:30 at $79.90 climbing to $84.31 by 09:50, and 2026-10-29 09:55 at $83.66 after intraday range $83.05–$84.40, indicating stabilizing momentum near $83.50–$84.00.

Support
$78.25
Resistance
$87.82
20-day SMA
$77.55
30d High
$102.81
30d Low
$67.25

Technical Analysis

Technical Indicators

RSI (14)
57.45
MACD
0.17 / Sig 0.14
50-day SMA
$73.67
20-day SMA
$77.55
5-day SMA
$74.84
ATR (14)
6.44

SMA alignment: 5-day $74.84 < 20-day $77.55 < 50-day $73.67 is irregular; price $83.95 is above all three, showing short-term strength but no clean bullish stack (50-day below 20-day). RSI 57.45 is moderate-positive, not overbought. MACD histogram +0.03 (macd 0.17 > signal 0.14) is marginally bullish. Bollinger: middle $77.55, upper $93.51, lower $61.60 — price near upper-third, no squeeze (wide bands). 30-day range high $102.81 / low $67.25; current $83.95 is ~50% up the range, below midpoint-retrace from high.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only):

Call Volume: $2,760.00 (100.00%) Put Volume: $0.00 (0.00%) Total: $2,760.00

Sentiment is Bullish with 3 call contracts, 0 puts, 2 call trades. Pure directional conviction is entirely bullish but on very low sample (2 of 244 options analyzed, 0.80% filter). Near-term expectations: tentative upside bias, no bearish hedge. Divergence: technical SMA stack is irregular and fundamentals negative, yet options show 100% call conviction — small-size optimism not confirmed by broader data.

Note: Options flow shows 100% call dollar volume in delta-40-60 bracket, the only sentiment source retrieved.

Key Price Levels (Observational Only)

Support (10-28 low)
$78.25
Resistance (10-28 high)
$87.82
Bollinger Lower
$61.60
Bollinger Upper
$93.51
50-day SMA
$73.67

Interactive charts load with JavaScript. This text is the crawlable summary.